·
4 Min Read

April 1, 2022: Advocacy Update other news

Upcoming webinars on the overdose epidemic and out-of-network payment process and more in the latest Advocacy Update other news.

Advocacy Update
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 14, 2022

In the news: Overdose deaths surge to a record high, older adults need second Pfizer COVID-19 booster and more.

Publications & Newsletters
·
2 Min Read

March 18, 2022: State Advocacy Update

Maryland bill would direct opioid litigation settlement funds to public health and treatment and more in the State Advocacy Update.

Advocacy Update
Person in grocery aisle
·
4 Min Read

Removing naloxone’s Rx status is an essential step to save lives

As the drug-overdose epidemic worsens, there is no moral, medical or safety-related reason for keeping naloxone locked under prescription regulations.

Behavioral Health
·
1 Min Read

AMA: Patients to benefit from Biden Administration Medicare Advantage

In a letter today, the AMA supported the Biden Administration’s proposal for Medicare Advantage network adequacy.

Press Releases
·
2 Min Read

March 4, 2022: State Advocacy Update

New Mexico Governor signs harm reduction bill and more in the latest State Advocacy Update.

Advocacy Update
Stethoscope draping a red toolkit
·
4 Min Read

Toolkit packed with evidence to help end drug-overdose epidemic

Some state officials are leading the way with science-driven policy that saves lives. It’s time their colleagues follow suit. Learn more with the AMA.

Behavioral Health
·
3 Min Read

Feb. 18, 2022: State Advocacy Update

New toolkit highlights effective policies in combating drug overdoses and more in the latest State Advocacy Update.

Advocacy Update
·
2 Min Read

AMA urges Administration to remove naloxone from behind the counter

Removing the prescription status of naloxone as an essential step to save lives from opioid-related overdose, helps to make naloxone available to patients.

Press Releases